KING PHARMACEUTICALS INC
8-K/A, EX-23.1, 2000-09-21
PHARMACEUTICAL PREPARATIONS
Previous: KING PHARMACEUTICALS INC, 8-K/A, 2000-09-21
Next: CONSOLIDATED EDISON INC, U-1/A, 2000-09-21



<PAGE>   1
                                                                    EXHIBIT 23.1



                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


As independent public accountants, we hereby consent to the inclusion of our
report dated July 31, 2000 on the American Home Products Corporation's
Wyeth-Ayerst Laboratories Division - Nordette, Bicillin, and Wycillin Product
Lines statement of Assets Acquired and Liabilities Assumed as of December 31,
1999 and the related statement of net Revenues in Excess of Direct Expenses for
the year ended December 31, 1999 in this current report on Form 8-K/A of King
Pharmaceuticals, Inc. dated July 7, 2000.


                                                       ARTHUR ANDERSEN LLP



Roseland, New Jersey
September 20, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission